Is it better to give dose 2 of the mRNA 2024-2025 Covid-19 vaccine at month 2 or month 6 after dose 1 in moderately immunocompromised patients?

This is a complicated question and unfortunately, we have no clear answer for it based upon clinical outcome data. The COVID-19 pandemic has changed dramatically since its inception over 4 years ago. Based on a combination of favorable viral evolution of diminishing pathogenic potential continuing t...